Delaney Davis to present PhD Defense titled, “Neurobehavioral and biochemical consequences of chronic, low-dose methamphetamine exposure in male and female mice”

In partial fulfillment of the requirements for the Doctor of Philosophy degree in the School of Biomedical Sciences, Delaney Davis will present a seminar entitled, “Neurobehavioral and biochemical consequences of chronic, low-dose methamphetamine exposure in male and female mice” on April 14, 2022, at 2:00 p.m. CST in EAD 514. A private defense with the advisory committee will immediately follow the seminar.

Delaney Davis is a doctoral candidate in Pharmacology and Neuroscience, under the supervision of Nathalie Sumien, Ph.D., Associate Professor.